MAAT INDEX

CLAIM #18213 · CVS Health Corp (CVS) · 2023Q2 earnings call · Aug 2, 2023 · due Dec 31, 2024

These efforts are expected to generate over $600 million of run rate savings beginning in 2024.

Karen Lynch · CEO

PENDING
graded after results covering Dec 31, 2024 are reported

In context

ating the resiliency of our front store offerings in a more challenging consumer environment. We also continue to make progress growing our digital members and sales. This quarter, we exceeded 53 million unique digital customers, up over 2 million from last quarter. Our digital sales increased 24% versus the prior year, including a meaningful increase of 65% in our over-the-counter health solution offering. This offering is highly valued by our health plan members, allowing them to conveniently access their important OTC benefits. Last quarter, we discussed optimizing our cost structure. This morning, we announced a restructuring charge of nearly $500 million associated with the elimination of approximately 5,000 non-customer facing positions as well as the impairment of non-core assets. These efforts are expected to generate over $600 million of run rate savings beginning in 2024. Our optimization efforts have also focused on identifying additional opportunities to drive efficiency and operational excellence using technology. For example, we’ve been selectively using artificial intelligence for some time and are increasingly finding opportunities to improve the efficiency of our operations, enhance our customer experience, and increase our competitiveness. When combining all of our productivity initiatives, we are confident we will achieve the $700 million to $800 million of cost savings that we are targeting in 2024. These actions enable us to reallocate resources and invest in critical growth areas such as health services and technology, which are the biggest enablers of our strategy. We’ve taken meaningful steps executing on our long term strategy with tangible

Verify independently

SEC filings for CVS · Claim quote is verbatim from the 2023Q2 earnings call.